Reality, as perceived by the patient, constitutes the reality of the situation. My Mother s Doing What???!!

Similar documents
Delirium. Assessment and Management

Delirium. A Geriatric Syndrome. Jonathan McCaleb, MD, CMD, HMDC UNSOM, Assistant Professor of Medicine Geriatrics / Hospice & Palliative Medicine

Management of Behavioral Problems in Dementia

Delirium. Delirium. Delirium Etiology and Pathophysiology. Fall 2018

BEHAVIORAL PROBLEMS IN DEMENTIA

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

Recognition and Management of Behavioral Disturbances in Dementia

Psychotropic Medication Use in Dementia

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist

Pharmacological Treatments for Neuropsychiatric Symptoms in Dementia 3/22/2018

2/12/2016. Drugs and Dementia in the Hospice Patient. Jim Joyner, Pharm.D., C.G.P. Director of Clinical Operations Outcome Resources

The Psychopharmacology of Alzheimer s Disease. Bruce Kaster, MD Instructor in Psychiatry Harvard Medical school

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan

Pharmacological Treatment of Aggression in the Elderly

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD

3/27/2013. Objectives. Psychopharmacology at the End of Life Nicole Thurston, MD

Antipsychotic use in Dementia care. Jabbar Fazeli, MD

Disclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA

Psychosis and Agitation in Dementia

Integrating INTERACT into Interim Pharmacist Reviews

Delirium in the ICU: Prevention and Treatment. Delirium Defined Officially. Delirium: Really Defined. S. Andrew Josephson, MD

Summary of Delirium Clinical Practice Guideline Recommendations Post Operative

Greg Jicha, M.D., Ph.D. Associate Professor of Neurology The Robert T. & Nyles Y. McCowan Chair in Alzheimer s Research University of Kentucky

Cognitive enhancers PINCH ME. Anticholinergic burden BPSD. Agitation, Aggression and antipsychotics

Delirium. Dr. Lesley Wiesenfeld. Deputy Psychiatrist in Chief, Mount Sinai Hospital. Dr. Carole Cohen

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017

Treatment Options for Bipolar Disorder Contents

Learning Objectives. Delirium. Delirium. Delirium. Terminal Restlessness 3/28/2016

Kelly Godecke, MD Department of Psychiatry University of Utah

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan

Antipsychotics for Dementia Under Control or Over-Prescribed?

Updates to CMS SOM rules on Psychosocial Issues, Deficiency Categorization, and Psychotropic Medication Use

10/5/2017. BEHAVIORAL and PSYCHOLOGICAL SYMPTOMS in DEMENTIA (BPSD) Dr. Shah MD, MPH Braodlawns Medical Center DISCLOSURE

Charles Bernick, MD, MPH Cleveland Clinic Lou Ruvo Center for Brain Health June 2, 2018

Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care

AACN PCCN Review. Behavioral

DELIRIUM. Approach and Management

Schedule FDA & literature based indications

Psychotropic Strategies Handout Package

Delirium in the Emergency Department. Emergency Medicine Rounds April 14, 2015 Paul R. Vanhoutte

Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults

Managing Challenging Behaviors

Antipsychotic Medications

Psychotropic Medication. Including Role of Gradual Dose Reductions

Practical Management of the Delirious Patient with Mental Retardation by the Nurse Anesthetist

Medication Audit Checklist- Antipsychotics - Atypical

TIAGABINE. THERAPEUTICS Brands Gabitril see index for additional brand names. Generic? Yes

GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT

12/17/2012. Unnecessary Drugs

Addressing Difficult Behaviors in Dementia

Psychiatric Medication Guide

Delirium. Dr. John Puxty

Delirium in the Elderly

NURSING HOME MEDICINE UPDATE

Behavioral Management in Dementia. a.k.a. Public Enemy Number One a.k.a. Proteins Gone Bad

Cognitive disorders. Dr S. Mashaphu Department of Psychiatry

Nursing Process Focus: Patients Receiving Chlorpromazine (Thorazine)

COMBATTING THE EXCESSIVE AND ILLEGAL USE OF PSYCHOTROPIC DRUGS ON PEOPLE WITH DEMENTIA IN NURSING FACILITIES

Decreasing Delirium Resolution Times for the Elderly: An Interprofessional Approach

Delirium. A Plan to Reduce Use of Restraints. David Wensel DO, FAAHPM Medical Director Midland Care

Management of the Acutely Agitated Long Term Care Patient

Optimal Management of Challenging Behaviours in Dementia: An Update on Pharmacologic and Non-Pharmacologic Approaches

PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA

MEDICATIONS IN MANAGING DIFFICULT BEHAVIORS

Managing Challenging Behaviors

Behavior Problems: in Long Term Care and Assisted Living

Delirium, Dementia, and Amnestic Disorders. Dr.Al-Azzam 1

Mental Health Issues in Nursing Homes. I m glad you asked.

Antipsychotics Detect, Select, Effect (P.I.E.C.E.S. 6 th Ed)

Evaluation and Management of Agitation and Aggression in Dementia Joseph W. Shega, MD National Medical Director

Caring for the Mind: Managing Depression and Anxiety. Highlights from 2017 ONS Congress

HDSA Annual Convention June 2013 Behavior Issues: Irritability and Depression Peg Nopoulos, M.D.

Medications and Non-Pharma Approaches to Treatment. David J. Irwin, MD Penn Frontotemporal Degeneration Center

Behavioral and Psychological Symptoms of dementia (BPSD)

Delirium in the Elderly

ANTIPSYCHOTICS IN LONG TERM CARE: Are We Doing More Harm than Good?

4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies

Chapter 12 1/29/2018. Schizophrenia and Schizophrenia Spectrum Disorders. Epidemiology. Comorbidity. Lifetime prevalence of schizophrenia is 1%

PRESCRIBING GUIDELINES

Psychiatric and Behavioral Challenges in HD

Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD

9/11/2012. Clare I. Hays, MD, CMD

Antidepressants. Dr Malek Zihlif

Do you know. Assessment of Delirium. What is Delirium? Which syndrome occurs more commonly in elderly populations? a. Delirium b.

Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines

Alcohol withdrawal. Clinical features

Behavior Problems: Dementia and Mental Illness in Long Term Care and Assisted Living Module III

N.C. Nurse Aide I Curriculum MODULE T. Dementia and Alzheimer s Disease. DHSR/HCPR/CARE NAT I Curriculum - July

Behavior Problems: in Long Term Care and Assisted Living

1/31/2009. Paroxysmal, uncontrolled electrical discharge of neurons in brain interrupting normal function

A Basic Approach to Mood and Anxiety Disorders in the Elderly

SYNOPSIS. Trial No.: RIS-USA-70 Clinical phase: III. JRF, Clinical Research Report RIS-USA-70, 16 October, 1998 N Trial period: Start: 20 Nov 95

Goals for sedation during mechanical ventilation

Session outline. Introduction to dementia Assessment of dementia Management of dementia Follow-up Review

BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA

Behavioral Issues in Dementia. March 27, 2014 Dylan Wint, M.D.

European PSUR Work Sharing Project CORE SAFETY PROFILE. Lendormin, 0.25mg, tablets Brotizolam

COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*

ADRC Dementia Care Training. Module 10: Supporting People with Serious Mental Illness and Dementia: Bipolar Disorders, Dementia, and Delirium

Transcription:

My Mother s Doing What???!! Management & Treatment of Dementia Related Behaviors Objectives Describe the prevalence, etiology of dementia related behaviors that include physical outbursts & sexual hyperactivity. Recognize nonpharmacologic & pharmacologic therapies Jody Agins MSN, RNP, FNP/GNP-BC jodyjfk@gotpharm.com Discuss follow up & avenues for long-term stabilization Agitation & Psychiatric Emergencies This Speaker has no disclosures Any condition that dangers self or others Increases morbidity & mortality 30% all admitted hospitalized elderly $100 billion annually on delirium in the hospital 60-85 % of elderly in ICU on ventilation Delirium in ICU: very strong predictor of dying with threefold rise of death within a year More than half of postoperative surgical pts 80% have treatable, reversible factors Reality, as perceived by the patient, constitutes the reality of the situation Common Causes of Agitation Muddied Waters

Renal Function and Fluid Imbalance Dehydration Electrolyte Imbalance Low serum albumin Renal Failure Acute or chronic Circulation & oxygenation Hypotension CV disease CHF Acute MI AA repair Low H / H Hypoxemia Sensory, Neurological & Functional Impairment Sensory disturbances Neurological disease Cognitive impairment Low activity levels Altered mobility Sleep / wake disturbances Poorly managed pain Urinary incontinence Head injury Metabolism, Infection, Trauma Metabolic disturbances Nutritional deficiency Abnormal glucose Liver dysfunction cirrhosis Abnormal body temperature Fractures & falls Orthopedic surgery Any infection (UTI) Emergency hospital admission Co-morbidities Drugs Psychoactive drugs Anticholinergic / CNS side effects Drug or alcohol abuse Toxicity Withdrawal Narcotic use Most Common Older Adult Agitation States Delirium Agitation: secondary to dementia Disinhibition & Sexual Behaviors > 4 medications

First thoughts History & Medication Review Time course of mental status changes? Association with other events? Pre-existing impairments of cognition or sensory modalities? Staff or family issues????? Any medications added, changed or stopped Diagnostics / Lab testing CBC CMP TSH, B-12, LFTs Ammonia level? RPR, HIV, CMV Infection workup (UA, CXR) + / - blood culture ECG CT; MRI / MRA head Epidemiology Delirium Common condition especially in dementia Organic etiology: 95% Death rate: 10-30% Up to 50% within following year Delirium is a medical emergency Psychomotor Variants of Delirium I WATCH DEATH Hyperactive: wild ~ 25% Hypoactive: pleasantly confused ~ 50% Mixed delirium with sundowning I Infection W Withdrawal A Acute metabolic T C H Trauma CNS pathology Hypoxia D Deficiencies E Endocrine A Acute vascular / MI T Toxins - drugs H Heavy metals

Things to AVOID RESTRAINTS - physical or chemical High dose or IV Haldol Excess anticholinergics or sedatives Can trigger or maintain PRN analgesics Premature label of dementia Stopping cholinesterase inhibitors Aricept, Razadyne, Exelon Pharmacological Treatment of Identifiable, Organic Causes Sleep - Short acting Benzo s (Ativan 0.5 mg) - Trazodone 25 mg, Remeron 7.5-15 mg Pain - Non-narcotic analgesics - Acetaminophen, Ibuprofen Alcohol withdrawal delirium Thiamine, Folate, Librium Infection Broad spectrum antibiotic Chronic Agitation In Dementia Agitation in Dementia Non Organic Cause Occurs in ~ 80% Psychosis occurs ~ 50% Physical aggression Hitting, kicking, biting Physical non-aggression Aggressive pacing Verbal aggressive agitation Cursing or screaming Centers for Medicare & Medicaid Services (CMS) Medication guidelines for facilities Restricted for psychotic disorders or specific, non-psychotic behavior with dementia Agitated behaviors: kicking, continuous screaming, biting, delusions Danger to self or others RT behaviors Document specific behaviors & need for medications & dosage OBRA87 Omnibus Budget & Reconciliation Act Otherwise known as the Nursing Home Reform Law Requires every nursing home to provide care and services in order for each resident to attain or maintain his/her highest practicable level of physical, mental and psychosocial well-being. Free from physical and chemical restraints, & be treated with dignity & respect

Omnibus Budget and Reconciliation Act of 1987 MUST attempt decrease in antipsychotic meds, including antidepressants, sleep meds every 6 months Nuedexta Dextromethorphan & Quinidine Cleveland Clinic published 2015 51% reduction in dementia related behaviors 26% reduction placebo Disinhibition & Sexual Behaviors Disinhibition: lack of restraint, including disregard for social conventions, impulsivity Discussing personal issues with strangers Making inappropriate comments (sometimes sexual) Standing uncomfortably close to others Taking food from other people s plates Taking clothes from other residents rooms Disinhibition & Sexual Behaviors Possible causes Damage to frontal lobes Misinterpreting caregiver s interaction or misidentifying caregiver Discomfort or irritation clothing too warm or tight, genital irritation, urinary retention or infection Medications (especially dopaminergic) Need for attention, gratification or intimacy Disinhibition & Sexual Behaviors Non-pharmacological Redirecting Verbal then physical Identify behavior & remind it s unacceptable Remind them who you are Choose clothing that opens in back Assign manual activities Folding towels Disinhibition & Sexual Behaviors Medications SSRIs Mood & impulse control Antiandrogens, estrogen, medroxyprogesterone acetate, leuprolide Cimetidine Antiandrogen properties Cholinesterase inhibitors Neuroleptics Benzodiazepines often increase disinhibition

What about Antiepileptics for Long Term Management??? Carbamazepine (Tegretol) Chemically related to TCAs Target: Verbal & physical aggression Black Box Warning Drug-induced bone marrow suppression CYP450 pathway (CYP3A4) inducer May increase metabolism of many other drugs Warfarin, estrogen, some statins, anticholinergics Carbamazepine (Tegretol) Side effects Sedation Tremor & ataxia Nausea Hyponatremia Leukopenia Hepatic toxicity Bradycardia & conduction delays Absorption decreased in NG feeding Mix with equal volume of dilutent Valproate Sodium (Depakote) Target: Agitation, aggression Has an anti-manic effect in older adults Protein bound Caution use in liver disease Monitor: CBC, LFT s, ammonia level? Drug-drug interactions: Increase levels: TCAs & SSRIs: Decreased levels: phenytoin & carbamazepine Valproate Sodium (Depakote) Prolonged half-life in older adults Side effects Sedation Tremor & ataxia Weight gain Thrombocytopenia GI disturbances- N / V, diarrhea Minimize with slow dose titration & low dosing Dosing & Lab Considerations

Lamotrigine (Lamictal) Stevens-Johnson syndrome Risk very low for older patients (0.03%) Side effects Agitation Anxiety Concentration problems Confusion Depression Irritability Mania Other Medications & Lamictal Medications that lower plasma level Phenobarbital & primidone: ~ 40% Estrogen: ~ 50% Depakote Can double plasma levels of Lamictal Dose should be ~ 1/2 usually initially prescribed Tegretol Facilitates metabolism Dose may need to be increased Lithium Interactions have not been reported Gabapentin (Neurontin) Not metabolized, no liver precautions Eliminated as unchanged drug by renal system Adjust dose with compromised renal function < 3% protein bound Elimination half-life: 5-7 hrs Very low adverse effects Somnolence, dizziness, fatigue, psychosis Great in pain management as well Namenda & Aricept, Razadyne, Exelon Considerations Cholinesterase Inhibitors Apathy, depression, anxiety Memantine (NMDA-Glutamate Receptor Antagonist) Delusions, hallucinations, agitation/aggression CMS: Antipsychotic Initiative Pharmacologic Treatment Reminders In the Older Adult Initiative to Improve Behavioral Health and Reduce the Use of Antipsychotic Medications in Nursing Homes Residents

CMS: Antipsychotic Initiative Only diagnoses carved out to use antipsychotics Schizophrenia Huntington s Chorea Tourette syndrome CMS: New Goals Set for 2017 Some States already set their own State specific goals Target reduction in short stay use of antipsychotic medication use Surveyor Guidance & F tags Separate Dementia Care Practices F309 (includes QI for pain, hospice, etc.) & separate out antipsychotic use from other unnecessary drug use currently addressed in F329 Second Generation Antipsychotics How Do We Switch? Better response & tolerability Less EPS / TD All metabolized in liver P450 precautions Decrease dose with liver dysfunction Black Box: entire class RT use in dementia behaviors Increased risk of death CVA Hyperglycemia pneumonia Urgent Medications Zyprexa M-tab (Onset of action also ~ 15 minutes) Risperidone M-tab Aripiprazole (Abilify) M-tab, liquid, IM Haloperidol IM Ziprasidone (Geodon) IM: Has not been evaluated in elderly patients Suspension Behaviors for which drugs WILL NOT HELP wandering, pacing hoarding or rummaging apathy

Pharmacologic Approaches Remember treat underlying source first Make sure you re treating the right thing! Depression, dementia, bipolar, schizophrenia Start low, go slow. BUT GO Don t be afraid to push doses or add adjunct medications Meds control agitation, restlessness, hostility Not impaired memory or indifference